Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer (original) (raw)

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893–2917.
  Article CAS Google Scholar
• Lee RC, Feinbaum RL, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843–854.
  Article CAS Google Scholar
• Pillai RS, Bhattacharyya SN, Filipowicz W . Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007; 17: 118–126.
  Article CAS Google Scholar
• Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.
  Article CAS Google Scholar
• Garzon R, Calin GA, Croce CM . MicroRNAs in Cancer. Annu Rev Med 2009; 60: 167–179.
  Article CAS Google Scholar
• Kent OA, Mendell JT . A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25: 6188–6196.
  Article CAS Google Scholar
• Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH . Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008; 283: 1026–1033.
  Article CAS Google Scholar
• Selcuklu SD, Donoghue MT, Spillane C . miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009; 37 (Part 4): 918–925.
  Article CAS Google Scholar
• Medina PP, Nolde M, Slack FJ . OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86–90.
  Article CAS Google Scholar
• Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008; 14: 2348–2360.
  Article CAS Google Scholar
• Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 2011; 224: 484–495.
  Article CAS Google Scholar
• Rosa A, Ballarino M, Sorrentino A, Sthandier O, De Angelis FG, Marchioni M et al. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA 2007; 104: 19849–19854.
  Article CAS Google Scholar
• Sarkar S, Dey BK, Dutta A . MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell 2010; 21: 2138–2149.
  Article CAS Google Scholar
• Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D et al. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J Clin Invest 2010; 120: 4141–4154.
  Article CAS Google Scholar
• Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008; 36: 5391–5404.
  Article CAS Google Scholar
• Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 2009; 114: 3255–3264.
  Article CAS Google Scholar
• Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T et al. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res 2011; 39: 1880–1893.
  Article CAS Google Scholar
• Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z, Sun J et al. microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem 2011; 286: 10725–10734.
  Article CAS Google Scholar
• Li J, Huang H, Sun L, Yang M, Pan C, Chen W et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009; 15: 3998–4008.
  Article CAS Google Scholar
• Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
  Article Google Scholar
• Witten D, Tibshirani R, Gu SG, Fire A, Lui WO . Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 2010; 8: 58.
  Article Google Scholar
• Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K et al. RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc Natl Acad Sci USA 2011; 108: 3336–3341.
  Article CAS Google Scholar
• Deryugina EI, Quigley JP . Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25: 9–34.
  Article CAS Google Scholar
• Yu W, Liu J, Xiong X, Ai Y, Wang H . Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathol Res Pract 2009; 205: 709–715.
  Article CAS Google Scholar
• Lin LF, Chuang CH, Li CF, Liao CC, Cheng CP, Cheng TL et al. ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer. Cancer Res 2010; 70: 192–201.
  Article CAS Google Scholar
• Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 2010; 24: 460–466.
  Article CAS Google Scholar
• Kawahigashi Y, Mishima T, Mizuguchi Y, Arima Y, Yokomuro S, Kanda T et al. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J Nihon Med Sch 2009; 76: 188–197.
  Article CAS Google Scholar
• Rentoft M, Fahlen J, Coates PJ, Laurell G, Sjostrom B, Ryden P et al. miRNA analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples. Int J Oncol 2011; 38: 61–69.
  CAS PubMed Google Scholar
• Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ . Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 2010; 11: 50–54.
  Article Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T . Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853–858.
  Article CAS Google Scholar
• Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ . miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34 (Database issue): D140–D144.
  Article CAS Google Scholar
• Wang Z, Wang M, Kar S, Carr BI . Involvement of ATM-mediated Chk1/2 and JNK kinase signaling activation in HKH40A-induced cell growth inhibition. J Cell Physiol 2009; 221: 213–220.
  Article CAS Google Scholar
• Lopez-Girona A, Tanaka K, Chen XB, Baber BA, McGowan CH, Russell P . Serine-345 is required for Rad3-dependent phosphorylation and function of checkpoint kinase Chk1 in fission yeast. Proc Natl Acad Sci USA 2001; 98: 11289–11294.
  Article CAS Google Scholar
• Bartek J, Lukas J . Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001; 13: 738–747.
  Article CAS Google Scholar
• Zhao H, Watkins JL, Piwnica-Worms H . Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci USA 2002; 99: 14795–14800.
  Article CAS Google Scholar
• Zachos G, Rainey MD, Gillespie DA . Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J 2003; 22: 713–723.
  Article CAS Google Scholar
• Madoz-Gurpide J, Canamero M, Sanchez L, Solano J, Alfonso P, Casal JI . A proteomics analysis of cell signaling alterations in colorectal cancer. Mol Cell Proteomics 2007; 6: 2150–2164.
  Article CAS Google Scholar
• Verlinden L, Vanden Bempt I, Eelen G, Drijkoningen M, Verlinden I, Marchal K et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas. Cancer Res 2007; 67: 6574–6581.
  Article CAS Google Scholar
• Ehlen O, Nodin B, Rexhepaj E, Brandstedt J, Uhlen M, Alvarado-Kristensson M et al. RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer. Transl Oncol 2011; 4: 212–221.
  Article Google Scholar
• Gao Q, Huang X, Tang D, Cao Y, Chen G, Lu Y et al. Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells. Apoptosis 2006; 11: 1789–1800.
  Article CAS Google Scholar
• Li YL, Ye F, Hu Y, Lu WG, Xie X . Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction. Anal Biochem 2009; 394: 110–116.
  Article CAS Google Scholar
• Shen Y, Li Y, Ye F, Wang F, Lu W, Xie X . Identification of suitable reference genes for measurement of gene expression in human cervical tissues. Anal Biochem 2010; 405: 224–229.
  Article CAS Google Scholar
• Li YL, Ye F, Cheng XD, Hu Y, Zhou CY, Lu WG et al. Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer. Eur J Cancer 2010; 46: 2104–2118.
  Article CAS Google Scholar
• Ye F, Hu Y, Lu W, Zhou C, Xie X . Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics. Histopathology 2008; 53: 224–228.
  Article CAS Google Scholar